Podcasts about Colorectal cancer

Gout, Bone Density, Colorectal Cancer, Novels, YouTube. You can NOT define me. SID HILLMAN – OXYGEN (VINYL & DIGITAL) Ultrarunning for Normal People: Life Lessons Learned On and Off the Trail Sid’s guest spot on “All Thing Endurance” Podcast Coaching: Private Coaching: SMALL STEP INTENSIVEOnline Program: SMALL STEPPERS MORE STUFF: PATREON BOOKS MUSIC

Featuring an interview with Dr Christopher Lieu, including the following topics: Historical approach to the adjuvant treatment of localized colorectal cancer (CRC) (0:00) Perspectives on earlier-onset colorectal cancer and potential drivers; management of oligometastatic disease (13:16) Overview of cell-free DNA (circulating tumor DNA [ctDNA]) and techniques for its measurement (17:03) Reliability and prognostic capability of ctDNA as a biomarker for clinical status in patients with localized colorectal cancer (21:10) ctDNA assessment and treatment decision-making for patients with Stage II colon cancer (26:38) Potential incorporation of ctDNA assays into the management of metastatic colorectal cancer or microsatellite instability-high disease (34:29) Available clinical data with ctDNA assessment in localized rectal cancer (38:54) Current practice patterns with ctDNA assays for patients with localized colorectal cancer (41:17) Case: A woman in her early 40s with resected lower risk Stage III colon cancer requests ctDNA testing (45:47) Case: A man in his early 50s with Stage IIIB colon cancer wants to avoid adjuvant chemotherapy (50:39) Case: A man in his early 60s with Stage IV colon cancer receives a positive postoperative ctDNA assessment result (53:24) NCPD information and select publications

In this podcast episode ... It's become the leading cancer killer of people under the age of 50, colorectal cancer. Once called the old person's disease it's now taking lives at a younger rate, we talk to a leading cancer specialist to find out more.

Send a textThe Oncology Journal Club Podcast hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson | Proudly Produced by The Oncology NetworkVisit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information. We explore practical wins and bold ideas across supportive care, colorectal cancer prevention, immunotherapy timing, digital triage and equity. From halving hot flushes with an NK1/NK3 blocker to biomarker-guided aspirin in colon cancer, we weigh value, risk and what truly improves lives.• Elinzanetant cutting severe hot flushes and improving treatment adherence• Current non-hormonal options and gaps in symptom control• Biomarker-selected aspirin reducing recurrences in colorectal cancer• Limits of DFS, toxicity trade-offs and subgroup signals• Rising early-onset colorectal cancer and system planning needs• Possible environmental and microbiome drivers under study• ASCO geriatric assessment guidance and G8 screening in clinics• PD-1 with short-course radiotherapy boosting rectal pCR rates• Large language models for safe, efficient symptom triage• Rare cancers report on access, cost, and rural inequities• Telehealth standards to link expertise closer to home• Healthy workplace culture to retain a resilient oncology workforceJoin the Oncology Network, registration is free, and leave us a voice note on the OJC page at oncologynetwork.com.au. Physicians, don't forget you can claim CME points for listening to the show!Thanks for listening

March is Colorectal Cancer Awareness Month, a national effort focused on increasing screening rates and educating patients about prevention and early detection. On this episode of the Health Matters Radio Show and Podcast, pharmacists Paul White and Brad White of Medicine Center Pharmacy spoke with Dr. Marta Lavery of Aultman General Surgery about colorectal cancer risk, screening options, and why early detection is so important.   https://www.medshoprx.com/blog/colorectal-cancer-screening-why-early-detection-can-save-your-life

March is Colorectal Cancer Awareness Month. In this month’s segment, X101's Matt Brooks is joined by Cortland County's Senior Public Health Educator, Courtney Maxson to talk about the importance of[Read More...] The post Make Sure to Schedule Your Screening for Colorectal Cancer appeared first on X101 Always Classic - WXHC.com.

Dr. Cedrek McFadden breaks down progress being made in colorectal cancer detection and treatment. Also, three inspiring women entrepreneurs share their stories. Plus, Cazzie David joins to talk about her new book ‘Delusions: Of Grandeur, of Romance, of Progress,' sharing personal stories and reflections ahead of her 30th birthday. And, bestselling author Myka Meier shares lessons on resetting kindness. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Beat Cancer host Chris Joyce speaks with Dr. Ankit Sarin, Chief of the Division of Colorectal Surgery for UC Davis Health and UC Davis Comprehensive Cancer Center, about the rise in colon and colorectal cancer incidences in younger (less than 50 years old) populations.To learn more about the UC Davis Comprehensive Cancer Center, visit https://health.ucdavis.edu/cancer/

This week, we explore early colorectal cancer. Maybe it's just this week, but there were plenty of “IDEAS” around. Michael highlights the importance of choosing an appropriate adjuvant regimen, whether that be FOLFOX or CAPOX. Josh digs a bit deeper and, as the name suggests, looks at whether patients with liver metastases can be cured with chemotherapy and a liver transplant.Studies discussed in this episode:IDEASTransMETEORTCFor more episodes, resources and blog posts, visit www.inquisitiveonc.comPlease find us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comArt courtesy of Taryn SilverMusic courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content. Hosted on Acast. See acast.com/privacy for more information.

This episode is all about colorectal cancer and what you need to know, especially as millennials. We'll break down the importance of education, prevention, risks or symptoms you shouldn't ignore, and why screening today isn't as scary or complicated as people might think. Our guest is Dr. Kent Peterson, a specialist in colorectal surgery at Sanford Broadway Clinic in Fargo, North Dakota. Our host is Courtney Collen with Sanford Health News.Learn more about Sanford Health at: http://www.news.sanfordhealth.orgConnect with us on social:FacebookTwitterInstagramLinkedIn

Drs. Cytryn, Foote, and Thummalapalli discuss recent data on HER2 testing modalities and the prevalence of HER2 positivity across hepatobiliary, upper GI, and colorectal cancers, highlighting implications for precision medicine. The conversation reviews the latest clinical trial findings and the evolving landscape of HER2-targeted therapies, with insights into optimal treatment sequencing for various GI cancer subtypes.

Featuring an interview with Dr Stacey A Cohen, Dr Arvind Dasari and Dr Christopher Lieu, including the following topics: Biological Principles Underlying Circulating Tumor DNA (ctDNA) Molecular Residual Disease (MRD) Testing in Colorectal Cancer (CRC) — Dr Cohen (0:00) Potential Utility of ctDNA Testing to Identify Patients with Localized CRC Who Might Benefit from Treatment De-escalation or Escalation — Dr Lieu (17:44) Role of ctDNA Analysis in the Management of Metastatic CRC – Dr Dasari (36:16) Clinical Investigator Survey Results (56:06) Case: A woman in her early 40s with mismatch repair-proficient/microsatellite-stable (MSS), low-risk Stage II colon cancer — Dr Lieu (1:23:05) Case: A woman in her early 70s with microsatellite instability-high Stage III colon cancer with a BRAF mutation — Dr Cohen (1:26:06) Case: A man in his mid 40s with metastatic CRC — Dr Dasari (1:31:57) Case: A man in his early 50s with low-risk Stage III colon cancer — Dr Lieu (1:37:54) Case: A man in his early 30s with MSS, high-risk Stage II CRC — Dr Cohen (1:50:17) Case: A woman in her early 50s with metastatic CRC — Dr Dasari (1:52:05) Case: A man in his early 60s with Stage IV colon cancer — Dr Lieu (1:56:05) CME information and select publications

Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.CME information and select publications here.

Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.CME information and select publications here.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a range of transformative events shaping the industry, from regulatory approvals and licensing deals to clinical trial outcomes and strategic partnerships, each carrying profound implications for drug development and patient care.Starting with the biopharma landscape in China, there's a notable shift in the valuation of licensing deals, which have seen a significant increase of 230% in upfront payments. This surge, from $52 million to $172 million between 2022 and early 2026, signals China's growing influence and competitiveness in the sector. Historically considered a low-cost option for licensing deals, China's enhanced innovation capabilities are now attracting Western companies seeking strategic collaborations. The implications are vast, offering Western firms an opportunity to tap into China's expansive market potential and leverage local expertise, underscoring the country's pivotal role in global drug development.In regulatory news, Pfizer's Braftovi (encorafenib) combination therapy has achieved full FDA approval for colorectal cancer treatment. This is a critical development, expanding therapeutic options for a particularly challenging cancer type. The approval highlights the increasing importance of targeted therapies in oncology, reflecting ongoing efforts to address unmet medical needs by enhancing the treatment arsenal available to clinicians. As cancer remains a major global health issue, such advancements are vital for improving patient outcomes.Novartis is making headlines with its substantial investment strategy to boost radiopharmaceutical production capabilities in the United States. With new manufacturing sites planned in Texas and Florida as part of a broader $23 billion investment, Novartis is positioning itself at the forefront of radiopharmaceuticals—a field offering innovative cancer treatments through targeted radiation delivery. This strategic move not only strengthens Novartis's presence in this burgeoning field but also signifies a broader industry trend towards cutting-edge technologies that promise more precise and effective treatment modalities.Shifting focus to drug pricing dynamics, Novo Nordisk has announced plans to reduce list prices for its GLP-1 medications, Ozempic and Wegovy, starting next year. While self-pay channels remain unaffected, this price reduction reflects broader industry trends towards addressing medication costs amidst mounting pressure from healthcare stakeholders. The move aims to enhance affordability for diabetes and obesity treatments, crucial given the rising prevalence of these conditions globally.In gene therapy, BioMarin has faced challenges with its hemophilia A gene therapy, Roctavian. Despite potential clinical benefits, BioMarin's efforts to divest the therapy have resulted in a $240 million financial setback. This scenario underscores the inherent complexities and financial risks associated with developing advanced therapies like gene therapies. Meanwhile, Pfizer has shown continued interest in gene editing technologies by securing global rights to Beam Therapeutics' liver-targeted gene editing candidate. This decision marks Pfizer's strategic pivot towards promising frontiers in therapeutic innovation.Emerging biotech BreezeBio has rebranded and secured $60 million in funding to advance its research in genetic medicine focused on restoring immune tolerance in type 1 diabetes. This strategic pivot towards addressing autoimmune diseases using innovative genetic approaches highlights ongoing efforts within the biotech sector to tackle complex health challenges through cutting-edge science.Collectively, these developments illustrate dynamic trends within the pharmaceutical and biotech sectors: a shift towards more equitable global partneSupport the show

Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.CME information and select publications here.

From chicken to dairy, learn how animal products increase cancer risk through hormones, heme iron, and carcinogens formed during cooking. #CancerPrevention #AnimalProteinRisks #HormonalHealth

#943: Join us as we sit down with Dr. Karan Rajan – doctor, health educator, & bestselling author of This Book May Save Your Life & This is Vital Information. Known across social media for debunking viral health trends, he's become one of the most trusted voices in gut & general health. In this episode, Dr. Karan Rajan breaks down the alarming rise of colorectal cancer, how gut health impacts hormonal conditions like endometriosis, the truth about fiber intake, what your GI tract is really trying to tell you, & debunks today's biggest viral health trends.   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with Dr. Karan Rajan click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Head to our ShopMy page HERE and LTK page HERE to find all of the products mentioned in each episode.   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   Shop LOAM at https://go.shopmy.us/p-43749215 and use code SKINNY20 for 20% off!    This episode is sponsored by The Skinny Confidential The beauty tool that started it all, redesigned to evolve with you. Shop Ice Roller at https://bit.ly/IceRollerSilver today.   This episode is sponsored by Beekeepers Natural's Go to http://beekeepersnaturals.com/SKINNY or enter code SKINNY to get 20% off your order!   This episode is sponsored by The American Beverage Association Visit http://goodtoknowfacts.org for more information.   This episode is sponsored by ARMRA Go to http://armra.com/SKINNY or enter SKINNY to get 30% off your first subscription order.   This episode is sponsored by The RealReal Get $25 off your first purchase when you go to http://TheRealReal.com/skinny.   This episode is sponsored by Ollie Go to http://ollie.com/skinny and use code skinny to get 60% off your first box!   This episode is sponsored by Just Thrive Get your health in check and save 20% on your first order at https://justthrivehealth.com/SKINNY.   This episode is sponsored by Bobbie If you want to feed with confidence too, head to http://hibobbie.com to find the formula trusted by parents and loved by their babies—700k and counting. Produced by Dear Media

WBBM's Rob Hart sits down with two doctors from City of Hope, Dr. Kevin King & Dr. Walter Stadler, to discuss the rising number of cases of colorectal cancer amongst younger people after the death of TV & film actor James Van Der Beek. They discuss the symptoms, when people should get tested and much more.

Colorectal cancer (cancer of the colon and rectum) is now the leading cause of cancer deaths in adults younger than 50. Rates have increased steadily over the past three decades, with the most dramatic rise seen in people in their 20s and 30s. In this episode we break down what that means for you and the people you love.  https://bit.ly/3OpPlk8Early colorectal cancer often has no symptoms at all, which is why screening guidelines were recently lowered to begin at age 45. When caught early, the five-year survival rate is 91%. When detected after it has spread, survival drops dramatically.We discuss:Why colorectal cancer is increasing in younger adultsThe subtle symptoms many people ignoreHow blood clots can complicate cancerLifestyle factors linked to riskWhy early-onset colorectal cancer tends to be more aggressiveHow to advocate for yourself if something feels “off”If you notice blood in your stool, persistent abdominal pain, changes in bowel habits, unexplained weight loss, or fatigue from anemia — do not dismiss it. Speak up. Get evaluated. Early detection can save your life.In this Episode:0:00 – Intro: Colorectal Cancer Cancer in Young Adults02:35 – Recipe: Yummy Ham & Pickle Rollups02:50 – “André Is An Idiot”: André Ricciardi's Terminal Creative Legacy 05:38 – Celebrity Case Studies: James Van Der Beek & Catherine O'Hara14:32 – Super Bowl Ad Alert: Multi-Cancer Tests & False Negatives16:54 – The Reality Check: Lifestyle Risks & Charlie's Personal Disclosure30:44 – Tracey Emin: Reclaiming Life After Radical Pelvic Surgery34:00 – Outro#ColorectalCancer #AndréRicciardi #TraceyEmin #JamesVanDerBeek #CatherineOHara #ColonCancer #CancerScreening #EarlyDetection #YoungAdultsHealth #CancerAwareness #PreventCancer #EveryoneDiesPodcast #KnowTheSigns #AdvocateForYourHealth Support the showGet show notes, images and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

The nation is still recovering after the devastating death of Dawson's Creek star, James Van der Beek. Colorectal cancer has been on the rise in young adults for years and is now the leading cause of cancer deaths overall in this age group. We spoke with wellness coach, Amy Llinas, about ways to lower the risk of getting this cancer.

Colorectal cancer is rising quickly among young adults – in fact, it's the leading cause of cancer deaths for adults under 50 in the United States. And after actor James Van Der Beek's diagnosis and death at 48, many are wondering how to tell when everyday symptoms might actually be something more serious. On this week's Paging Dr. Gupta, we break down the red flags and tell you what to know about screening. Plus, vibration plates are popping up in gyms and living rooms — but do they actually deliver the benefits they promise?  More on what's behind the rise of colon cancer in young people with Dr. Kimmie Ng. This episode was produced by Andrea Kane, Jennifer Lai and Kyra Dahring.  Showrunner: Amanda Sealy  Senior Producer: Dan Bloom Technical Director: Dan Dzula Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Jim Adams, Chief Medical Officer of Northwestern Medicine, joins Wendy Snyder, filling in for Lisa Dent, to discuss several health topics. He shares some information about colorectal cancer and its warning signs, whether or not people who have gotten the measles vaccine need a booster, and some lifestyles changes people can make to help reduce their […]

RFK Jr.'s admission on Theo Von's podcast interview, Dawson's Creek Star James Van Der Beek's cause of death, Dr. Oz speaking up about the measles vaccine, Celine Dion's stiff person syndrome, a Big Brother star's stroke from a hole in her heart, and Montell Jordan sharing that he's cancer free all come together in this week's live show, and we're digging into what it really means for our health.We'll break down RFK Jr.'s admission of snorting illegal substances off a toilet seat and talk honestly about public bathroom germs and how infections actually spread. We're also honoring Dawson's Creek Star James Van Der Beek's cause of death from colorectal cancer and what this can teach about our own health.We'll also cover the rising measles numbers, and we'll clear up myths about stiff person syndrome, explain what a PFO is and how it can lead to a stroke, and end with good news by discussing Montell Jordan and the power of a simple PSA test. Join us live and bring your questions as we turn these trending medical headlines and celebrity health news into real health wins.#HealthHappyLifePodcast #DrFrita #DrFritaLIVE! #CelebrityHealthNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss the importance of screening for colorectal cancer and why doctors aren’t agreeing when it comes to diagnosing Alzheimer’s. He also talks about healthy heart habits, foods than can help lower blood pressure, and how your brain functions when you don’t […]

February 16, 2026 ~ Dr. Sumit Singla, MD, Senior Staff, Advanced Therapeutic Endoscopy. Chief of Gastroenterology and Hepatology, Henry Ford Health discusses the spike in colorectal cancer deaths in people under 50 after James Van Der Beek dies at 48. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

(00:00:00) We begin with the remarkable history of the League of Women Voters, born in 1920 from the women’s suffrage movement and led by NAWSA president Carrie Chapman Catt. Created six months before the ratification of the 19th Amendment, the League set out to help newly enfranchised women learn how to register, how to vote, and how their government worked. In Pennsylvania, LWV chapters in cities like Pittsburgh and Philadelphia mobilized quickly, registering thousands of women and building a culture of informed civic participation. More than a century later, the League’s mission has expanded across every state — and even to the US Virgin Islands and Hong Kong — continuing its work to strengthen democracy through education and engagement. (00:22:19) Then we turn to another essential form of empowerment: colorectal cancer prevention. Experts explain why colorectal cancer is both common and highly preventable, how routine screening beginning at age 45 can detect cancer early or remove precancerous polyps, and why understanding personal and family risk is critical. We also explore the lifestyle choices — from diet to physical activity — that significantly reduce risk and help people take control of their long‑term health. Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Dr. John Ashcraft from University of Kansas Health System talks increased rates of colorectal cancer in young adults HR 2 full 2638 Fri, 13 Feb 2026 16:02:57 +0000 m8ioNBtLBQ5TLegDYDPfkpE09mklxJ7I news MIDDAY with JAYME & WIER news Dr. John Ashcraft from University of Kansas Health System talks increased rates of colorectal cancer in young adults HR 2 From local news & politics, to what's trending, sports & personal stories...MIDDAY with JAYME & WIER will get you through the middle of your day! © 2025 Audacy, Inc. News False

Super Bowl Sunday is an actual holiday in the Shakoor family. This week we're talking hosting, nostalgia, the collective viewing experience, and why the West Coast kickoff time just hits different.Jill's back at work with mat leave officially in the rearview mirror and the whiplash is real. Holly starts a writing class and immediately spirals after reading something very personal out loud. Vulnerability hangovers are real.We get into evolving friend groups, mommy-and-me leveling up, and why Take On Me, specifically the acoustic version, will never sound the same again.Still going thru it. Still taking it on. Take On Me (acoustic) Connect with US on insta  

This hour, Ian Hoch has on Brian Wolshon, Professor of Civil Engineering at LSU and reminds listeners to get their colon checked out

Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer This study analyzed data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to look for an association between alcohol intake and colorectal cancer (CRC) or colorectal adenoma. Participants' lifetime pattern of alcohol intake was determined from a dietary history recorded as part of the PLCO trial. Current drinkers with a lifetime average of over 14 drinks per week had a higher CRC risk than those with under 1 drink per week (HR 1.25, p = .003) and an even higher risk of rectal cancer (HR 1.95). There was no consistent association between alcohol intake and colorectal adenoma risk, however results suggested that former drinkers may have a reduced risk of adenoma. They discussed potential mechanisms such as acetaldehyde, a known carcinogen and product of alcohol metabolism, and effects of alcohol on gut microbiome. They conclude that heavy alcohol intake increases CRC risk and that alcohol cessation may lower adenoma risk.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:  Introduction (0:00) Neoadjuvant Treatment for Localized Colorectal Cancer (CRC) — Dr Seligmann (2:39) Emerging Novel Approaches to Adjuvant Treatment for Localized CRC — Dr Lieu (33:18) Role of Circulating Tumor DNA Testing in Localized CRC — Dr Cohen (59:43) CME information and select publications

Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.CME information and select publications here.

Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.CME information and select publications here.

Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.CME information and select publications here.

Michael Sapienza, CEO of the Colorectal Cancer Alliance, calls for urgent action, with colorectal cancer now the leading cancer killer for people under 50.

On today’s episode of Ask the Dr, Dr. Michael Lange is joined by Roger Schulman for an important discussion on colorectal cancer and natural ways to help reduce risk. They talk about lifestyle and nutrition strategies that support gut health, overall wellness, and longevity. The focus is not just on surviving, but on truly thriving as we age. Topics discussed include: • Colorectal cancer and prevention-focused lifestyle choices • Natural ways to support gut and colon health • The benefits of Creapure creatine, MyHMB, and vitamin D • How Fortifeye Creatine + MyHMB + Vitamin D can support muscle, strength, and cognitive function • Why resistance training is essential for healthy aging and longevity • The importance of eating more fruits and vegetables • The role of omega-3s in RTG form for inflammation, heart, and brain health A powerful call-in from Tony: Tony calls into the show to share his incredible transformation, having lost over 250 pounds. He discusses how building muscle, improving his nutrition, and using proper supplementation dramatically improved his blood chemistries, overall systemic health, and ocular health. His journey is a real-life example of what is possible when you commit to lifestyle change and longevity-focused habits. Dr Lange mentions the Fortifeye Fit Meal is in manufacturing now and should be available soon. He also mentioned Fortifeye Fit Bites will be a chocolate raspberry gummy avaialble soon to curb appetite Special reminder: The last day for the BOGO on Fortifeye Vegan Super Protein is Monday. This episode is packed with practical, real-world strategies to help you build muscle, protect your brain, improve gut health, and thrive long term. Like, subscribe, and share Ask the Dr with anyone who wants to thrive, not just survive. #GutHealth #MuscleBuilding #ResistanceTraining #CognitiveHealth #TotalBodyWellness #fortifeyefitmealSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

We are in Week 2 of our 4-part series on Cancer, the #2 killer in America.  Dr. Prather talks about why Structure-Function Care and Disease Care must work together to get the best outcomes for patients.  In this episode, you'll find out:—How Holistic Integration's Structure-Function approach helps support patients going through Cancer treatments by keeping the body healthy and in homeostasis. —The story of the oncologist who called Dr. Prather about a terminal Prostate Cancer patient to ask what was being done to his patient because his PSA numbers were improving so dramatically. —The importance of Iodine for Breast Cancer and Fibrocystic Breasts  And how it has been shown to be effective for Prostate Cancer, Colorectal Cancer, and other types of Cancer as well. —Why Vitamin D is critical for Cancer and plays a huge role in our immune system.  And how Dr. Prather finds very few patients come in with proper Vitamin D levels.—The reason Dr. Prather refers to distilled water as "Cancer water".  And why you shouldn't drink too much alkaline water because Cancer cells are extremely alkaline.—The herbals that have anti-Cancer properties and are excellent for detoxification and for boosting the immune system. —Why an evaluation of nutritional deficiencies should be done to prevent and fight Cancer.  And why Anemia is something that should be taken seriously and can impact the survival rate from Cancer by 50%.—How Estrogen dominance can kick off Breast Cancer and Uterine Caner in Women.  And how almost all Prostate Cancers come from Estrogen dominance.—The astonishing story of the experiment Dr. Prater did as a student where rats who ate Wonder Bread "lost their hair, couldn't decide what sex they were, ate their young, and society just fell apart."—How Cancer patients who receive Acupuncture have 85% fewer symptoms and their fatigue levels are much les because "Acupuncture recharges the cells in the body".http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

Colorectal cancer is rising in younger adults, with U.S. rates increasing 2.4% per year since 2012. New evidence points to dietary changes as a contributing factor A recent study in JAMA Oncology found that those consuming the most ultraprocessed foods had a 45% higher risk of developing precancerous colorectal tumors before age 50 Risk increased with higher ultraprocessed food intake, then plateaued beyond seven to eight servings daily. Sweetened beverages, sauces, spreads, and condiments showed the strongest links You can reduce ultraprocessed food intake by planning real meals, replacing snack foods with whole ingredients, tracking triggers, and making unprocessed options more visible and accessible in your home Lowering your linoleic acid intake, increasing fiber gradually, and supporting gut health with protective foods and habits also helps reduce your risk of colorectal cancer

For people who've had colorectal cancer, celecoxib, a commonly prescribed medicine for pain, may help avoid disease recurrence, a recent analysis of a larger study found. Kimmel Cancer Center director William Nelson at Johns Hopkins explains that the presence of … Can the drug celecoxib help some people avoid colorectal cancer recurrence? Elizabeth Tracey reports Read More »

Featuring an interview with Dr Scott Kopetz, including the following topics:  Circulating tumor DNA (ctDNA)-guided adjuvant chemotherapy de-escalation in the treatment of Stage III colon cancer from the ctDNA-negative cohort of the DYNAMIC-III trial (0:00) Prognostic and predictive role of ctDNA in the management of Stage III colon cancer treated with celecoxib: Findings from the CALGB (Alliance)/SWOG 80702 trial (8:01) Phase III ALTAIR study comparing trifluridine/tipiracil to placebo for patients with molecular residual disease after curative resection of colorectal cancer (CRC); a methylation-based, tissue-free ctDNA test (12:51) ctDNA with locally advanced mismatch repair-deficient/microsatellite instability-high solid tumors; real-world evidence regarding ctDNA with resected CRC (17:31) CME information and select publications

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer. CME information and select publications here.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer. CME information and select publications here.

Featuring an interview with Dr Scott Kopetz, including the following topics: Circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) and survival among patients with resectable colorectal cancer (CRC) in the CIRCULATE-Japan GALAXY trial (0:00) ctDNA for detection of MRD in patients with CRC in the BESPOKE CRC and INTERCEPT trials (3:11) Clinical utility of including ctDNA monitoring in standard CRC surveillance (11:11) ctDNA analysis guiding adjuvant therapy for CRC in the DYNAMIC and CIRCULATE-North America trials (15:52) CME information and select publications

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.CME information and select publications here.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.CME information and select publications here.

In this episode of the Oncology Brothers podcast, we dived into the latest discussions surrounding metastatic colorectal cancer, focusing on treatment strategies for refractory cases. We recapped our recent discussions with GI experts, including Dr. John Strickler, Dr. Chiara Cremolini, Dr. Namrata Vijayvergia, and Dr. Tiago Biachi. Key topics included: * The importance of next-generation sequencing (NGS) and biomarker testing in treatment planning. * An overview of second-line treatment options such as Tas-102 with Bevacizumab, Regorafenib, and Fruquintinib, along with their respective clinical trial data. * Insights into side effect management and quality of life considerations for patients undergoing palliative treatment. * A discussion on the recent STELLAR-303 study and its implications for immunotherapy in colorectal cancer. Join us as we bridge the gap between academia and community practice, emphasizing the need for improved treatment options and patient care in the realm of refractory colorectal cancer. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more practice-changing updates! #ColorectalCancer #mCRC #TAS102 #Regorafenib #PalliativeCare #OncologyBrothers #GIOcology

I am dedicating today's entire episode to colonoscopies.  When I had my fifth colonoscopy yesterday, I shared the before-and-after experience online and received a flood of responses. Healthcare professionals thanked me for the transparency, while many followers admitted they were anxious, postponing their own procedures, or worried about the small likelihood of complications.  With my own strong family history of precancerous polyps and years of firsthand experience, I wanted to dive deeper so I can speak from both knowledge and empowerment. Join me as I unpack the facts to dispel your fears and bring a sense of calm confidence to this potentially life-saving procedure. IN THIS EPISODE, YOU WILL LEARN: How the rising incidence of colorectal cancer in younger women has led to a need for earlier detection  How colorectal cancer symptoms often get misattributed to stress, perimenopause, hemorrhoids, or other hormonal changes The risk factors of colonoscopies Various types of colonoscopy prep  How colonoscopy prep impacts the gut microbiome How probiotics can help reduce post-colonoscopy GI symptoms What women need to know about sessile serrated polyps How perimenopause and menopause alter colorectal cancer risk in women What major clinical trials reveal about prevention and long-term protection Some alternatives to traditional colonoscopy Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Research Links: Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death Response: Re: Mobile Phone Use and Brain Tumors in Children and Adolescents: A Multicenter Case–Control Study Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial—SCORE  Blood Test Could Provide Colonoscopy Alternative for Colorectal Cancer Screening Alteration in gut microbiota after colonoscopy: proposed mechanisms and the role of probiotic interventions Adverse events related to colonoscopy: Global trends and future challenges 

BUFFALO, NY - December 17, 2025 – A new #research paper was #published in Oncotarget (Volume 16) on December 15, 2025, titled “Machine learning-based survival prediction in colorectal cancer combining clinical and biological features.” In this study, led by Lucas M. Vieira from the University of Brasília and the University of California San Diego, researchers used machine learning to predict survival in patients with colorectal cancer. They built a model by combining biological markers with clinical data. This approach could help improve prognosis and guide treatment strategies for one of the world's most common and deadly cancers. The team analyzed data from over 500 patients, using clinical details such as age, chemotherapy status, and cancer stage, along with molecular features like gene expression and microRNAs. Their goal was to improve how clinicians identify high-risk patients and make outcome predictions more precise. Researchers evaluated three different patient data scenarios using different machine learning techniques. The best-performing was an adaptive boosting model, which achieved 89.58% accuracy. This approach showed that integrating clinical and biological data led to significantly better predictions than using either data type alone. Among the biological markers, the gene E2F8 was consistently influential in all patient groups and is known to play a role in tumor growth. Other important markers included WDR77 and hsa-miR-495-3p, which are also associated with cancer development. Key clinical predictors included cancer stage, patient age, lymph node involvement, and whether chemotherapy was administered. “The proposed method combines biological and clinical features to predict patient survival, using as input data from patients from the United States, available in the TCGA database.” Unlike earlier models that relied on either clinical or molecular data alone, this study demonstrates the added value of combining both. Ensemble methods, which merge multiple learning algorithms, provided more stable and consistent results across all patient groups tested. These research findings could lead to new tools that help clinicians better predict how a patient's disease might progress or respond to treatment. The study also highlights the importance of collecting complete clinical information, such as lifestyle factors, which were missing from the dataset but could enhance future predictions. Overall, the study demonstrated how machine learning can support more accurate and personalized survival predictions in colorectal cancer. It also points to potential future research on markers like E2F8, which may be useful for monitoring or targeted therapy. DOI - https://doi.org/10.18632/oncotarget.28783 Correspondence to - Lucas M. Vieira - lvieira@health.ucsd.edu Abstract video - https://www.youtube.com/watch?v=cy7UL5ZUKuI Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28783 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, colorectal cancer, machine learning, feature selection, non-coding RNAs, genes To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Join host Talaya Dendy on Navigating Cancer TOGETHER for another inspiring conversation with the truly remarkable Wenora Johnson.Wenora is a three-time cancer survivor (colorectal, endometrial, and basal cell carcinoma) and a passionate patient and research advocate. In this episode, she shares her incredible, decades-long journey and how her background in the Navy instilled the grit and discipline she needed to face these health challenges.What You'll Learn:Lynch Syndrome & Genetic Testing: Wenora discusses the pivotal role that genetic testing and the discovery of Lynch syndrome played in her early detection and survival. This segment is a must-listen for anyone considering testing.The Power of Policy Change: Hear about Wenora's dedicated work in patient advocacy, including her efforts to push for policy changes that would lower the recommended age for initial colonoscopies.Self-Advocacy & Resilience: Get real-world advice on how to stand up for yourself in the healthcare system and how Wenora harnessed her inner resilience to overcome multiple diagnoses.Caregiving Insights: The conversation touches on the often-overlooked challenges and realities faced by caregivers.Whether you are a patient, a caregiver, or simply looking for a story of extraordinary determination, Wenora's insights and message of hope are invaluable. Don't miss this episode!✨Episode Highlights:02:12 Meet Wenora Johnson: A Three-Time Survivor06:22 The Impact of Lynch Syndrome on Her Journey10:08 Why Genetic Testing Is So Important16:04 Fighting for Change: Advocacy and Policy33:00 Understanding Caregiving Challenges36:19 Tips for Self-Advocacy and Building Resilience43:19 Wenora's Final Thoughts and Resources (FORCE)Transcript: https://bit.ly/podscript177Resource: FORCE, https://www.facingourrisk.org/about-usInspired by Wenora's resilience? Start your journey with calm. Download your FREE Guided Meditation: "Calming Your Mind After a Cancer Diagnosis." Get inner peace now! https://www.ontheotherside.life/guidedmeditation